1204 A Phase I study evaluating the pharmacokinetics (PK) and pharmacodynamics (PD) of the oral pan-phosphoinositide-3 kinase (PI3K) inhibitor GDC-0941

Autor: Kristeleit, R., Sarker, D., Forster, M., Lolkema, M., Olmos, D., Mazina, K., Dolezal, M.V., Ware, J.A., Yan, Y., de Bono, J.S.
Zdroj: In EJC Supplements 2009 7(2):121-121
Databáze: ScienceDirect